Molina Healthcare (NYSE:MOH) Downgraded by StockNews.com to Buy

Molina Healthcare (NYSE:MOH) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

MOH has been the topic of a number of other research reports. Truist Financial dropped their price objective on shares of Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Barclays cut their price objective on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating for the company in a research report on Friday. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $350.00 price objective (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Wells Fargo & Company increased their target price on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a report on Monday, November 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $355.67.

Molina Healthcare Price Performance

MOH opened at $283.92 on Friday. The company’s 50-day simple moving average is $298.55 and its two-hundred day simple moving average is $318.15. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54. The stock has a market capitalization of $16.24 billion, a P/E ratio of 14.42, a P/E/G ratio of 0.96 and a beta of 0.54. Molina Healthcare has a 52-week low of $272.69 and a 52-week high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.92% and a return on equity of 27.88%. As a group, analysts predict that Molina Healthcare will post 23.44 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MOH. True Wealth Design LLC increased its holdings in shares of Molina Healthcare by 2,500.0% in the third quarter. True Wealth Design LLC now owns 104 shares of the company’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Versant Capital Management Inc grew its holdings in Molina Healthcare by 83.1% during the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after buying an additional 74 shares in the last quarter. Wingate Wealth Advisors Inc. bought a new stake in Molina Healthcare in the 4th quarter worth approximately $52,000. Financial Perspectives Inc purchased a new stake in shares of Molina Healthcare during the 4th quarter worth approximately $59,000. Finally, Lindbrook Capital LLC boosted its position in shares of Molina Healthcare by 38.5% during the 4th quarter. Lindbrook Capital LLC now owns 205 shares of the company’s stock valued at $60,000 after acquiring an additional 57 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.